Tenet Healthcare (THC) Receives a Hold from Barclays


Barclays analyst Steven Valiquette maintained a Hold rating on Tenet Healthcare (THC) yesterday and set a price target of $26. The company’s shares closed yesterday at $28.26.

According to TipRanks.com, Valiquette is a 3-star analyst with an average return of 3.1% and a 48.5% success rate. Valiquette covers the Services sector, focusing on stocks such as AmerisourceBergen Corporation, Patterson Companies Inc, and WellCare Health Plans.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Tenet Healthcare with a $30.67 average price target, representing an 8.5% upside. In a report issued on February 26, Merrill Lynch also maintained a Hold rating on the stock with a $30 price target.

See today’s analyst top recommended stocks >>

The company has a one-year high of $39.74 and a one-year low of $16.61. Currently, Tenet Healthcare has an average volume of 1.49M.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Tenet Healthcare Corp. engages in the provision of health care services. Through its subsidiaries and affiliates, it owns and facilitates acute care hospitals, ambulatory surgery centers, diagnostic imaging centers, and related health care facilities.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts